NASDAQ Composite: ( -0.71%) 17 733

S&P 500 Futures
(0.20%) 5 532.75 points

Dow Jones Futures
(0.16%) 39 531 points

Nasdaq Futures
(0.22%) 19 970 points

Oil
(0.76%) $82.16

Gas
(-0.96%) $2.58

Gold
(-0.21%) $2 334.60

Silver
(-0.20%) $29.50

Platinum
(0.46%) $1 006.50

USD/EUR
(-0.50%) $0.929

USD/NOK
(-0.63%) $10.61

USD/GBP
(-0.25%) $0.789

USD/RUB
(1.64%) $87.13

Actualizaciones en tiempo real para Sarepta Therapeutics, [0L35.L]

Bolsa: London Stock Exchange Sector: Healthcare Industria: Medical - Pharmaceuticals

Última actualización28 jun 2024 @ 13:55

25% discount on Stockinvest.us - Use code: Podcast

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 jun 2024 @ 13:55):
Our systems believe the stock currently is overvalued by -1.25% compare to its pairs and should correct downwards.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Volumen de hoy	351
Volumen promedio	424
Capitalización de mercado	15.00B
EPS	$0.380 ( Q1 \| 2024-05-01 )
Próxima fecha de ganancias	( $0 ) 2024-07-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-37.02 (Sector) 0 (Industry) 0
ATR14	$1.006 (0.64%)